Advances in detection methods of circulating breast-tumor cells

Chinese Journal of Cancer Prevention and Treatment

Volumn 17, Issue 19, 2010, Pages 1586-1590

  Qi, Xiao Wei ^a   Jiang, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Neoplasm circulating cells; Review literature

Indexed keywords

BIOLOGICAL MARKER;

BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CELL COUNT; CELL STRUCTURE; CIRCULATING TUMOR CELL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMBASE; HUMAN; MEDLINE; PROCEDURES CONCERNING CELLS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUMOR CELL;

EID: 78751530688     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Asworth T R. A case of cancer in which cells similar to those in tumors were seen in the blood after death [J]. Aust Med J, 1869, 14: 146-149.
2. Liu M C, Shields P G, Warren R D, et al. Circulating tumor cells, a useful predictor of treatment efficacy in metastatic breast cancer[J]. J Clin Oncol, 2009, 27(31): 5153-5159.
3. Xenidis N, Ignatiadis M, Apostolaki S, et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer[J]. J Clin Oncol, 2009, 27(13):2177-2184.
4. Talasaz A H, Powell A A, Huber D E, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device [J]. Proc Natl Acad Sc2i USA, 2009, 106(10) :3970-3975.
5. Ameri K, Luong R, Zhang H, et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype [J]. Br J Cancer, 2010, 102(3) :561-569.
6. Polyak K, Weinberg R A. Transitions between epithelial and mesenchymal states, acquisition of malignant and stem cell traits [J]. Nat Rev Cancer, 2009, 9(4):265-273.
7. Sieuwerts A M, Kraan J, Bolt J, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normallike breast tumor cells [J]. J Natl Cancer Inst, 2009, 101(1): 61-66.
8. Müller V, Alix-Panabières C, Pantel K. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies [J]. Eur J Cancer, 2010, 46(7) :1189-1197.
9. Deng G, Herrler M, Burgess D, et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients [J]. Breast Cancer Res, 2008, 10(4), R69.
10. Myung J H, Launiere C A, Eddington D T, et al. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM, implications for the effective separation of circulating tumor cells (CTCs) [J]. Langmuir, 2010, 26(11), 8589-8596.
11. Meng S, Tripathy D, Frenkel E P, et al. Circulating tumor cells in patients with breast cancer dormancy [J]. Clin Cancer Res, 2004, 10(24):8152-8162.
12. Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells, a new method for the immunomorphological and molecular characterization of circulating tumor cells [J]. Am J Pathol, 2000, 156(1) :57-63.
13. Qi X W, Yang X H, Fan L J, et al. Association between the spread of circulating tumor cells and breast cancer subtypes [J]. Breast Cancer Res, 2010,12(3) :402.
14. Ntouroupi T G, Ashraf S Q, McGregor S B, et al. Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope [J]. Br J Cancer, 2008, 99(5): 789-795.
15. Allard W J, Matera J, Miller M C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J]. Clin Cancer Res, 2004, 10(20):6897-6904.
16. Riethdorf S, Fritsche H, Müller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer, a validation study of the CellSearch system [J]. Clin Cancer Res, 2007, 13(3) :920-928.
17. Cristofanilli M, Budd G T, Ellis M J, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J]. N Engl J Med, 2004, 351 (8):781-791.
18. Cristofanilli M, Hayes D F, Budd G T, et al. Circulating tumor cells, a novel prognostic factor for newly diagnosed metastatic breast cancer [J]. J Clin Oncol, 2005, 23(7) ,1420-1430.
19. Riethdorf S, Müller V, Zhang L, et al. Detection and HER2 expression of circulating tumor cells, prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial[J]. Clin Cancer Res, 2010, 16(9): 2634-2645.
20. Nagrath S, Sequist L V, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology [J]. Nature, 2007, 450(7173): 1235-1239.
21. Maheswaran S, Sequist L V, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells [J]. N Engl J Med, 2008, 359(4):366-377.
22. Hsieh H B, Marrinucci D, Bethel K, et al. High speed detection of circulating tumor cells [J]. Biosens Bioelectron, 2006, 21(10): 1893-1899.
23. Pachmann K, Heiss P, Demel U, et al. Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC)? [J]. Clin Chem Lab Med, 2001, 39(9):811-817.
24. He W, Wang H, Hartmann L C, et al. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry [J]. Proc Natl Acad Sci, 2007, 104(28) ,11760-11765.
25. Galanzha E I, Shashkov E V, Kelly T, et al. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells [J]. Nat Nanotechnol, 2009, 4(12) ,855-860.
26. Alix-Panabières C, Vendrell J P, Pellé O, et al. Detection and characterization of putative metastatic precursor cells in cancer patients [J]. Clin Chem, 2007, 53(3) ,537-539.
27. Van der Auwera I, Peeters D, Benoy I H, et al. Circulating tumour cell detection, a direct comparison between the Cell Search System, the AdnaTest and CK-19/mammaglobin RTPCR in patients with metastatic breast cancer [J]. Br J Cancer, 2010, 102(2):276-284.
28. Ignatiadis M, Xenidis N, Perraki M, et al. Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early breast cancer [J]. J Clin Oncol, 2007, 25(33) :5194-5202.
29. Gilbey A M, Burnett M, Coleman R E, et al. The detection of circulating breast cancer cell in blood [J]. J Clin Pathol, 2004, 57(9):903-911.
30. Gervasoni A, Monasterio Munoz R M, Wengler G S, et al. Molecular signature detection of circulating tumor cells using a panel of selected genes [J]. Cancer Lett, 2008, 263(2) :267-279.
31. Tewes M, Aktas B, Welt A, et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer, an option for monitoring response to breast cancer related therapies [J]. Breast Cancer Res Treat, 2009, 115(3): 581-590.
32. Fehm T, Hoffmann O, Aktas B, et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells [J]. Breast Cancer Res, 2009, 11(4): R59.
33. Aktas B, Tewes M, Fehm T, et al. Stem cell and epithelialmesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients [J]. Breast Cancer Res, 2009, 11(4): 46.
34. Meng S D, Tripathy D, Shete S, et al. HER-2 gene amplification can be acquired as breast cancer progresses [J]. Proc Natl Acad Sci, 2004, 101(25) :9393-9398.
35. Klein C A, Seidl S, Dutter K P, et al. Combined transcriptome and genome analysis of single micrometastatic cells [J]. Nat Biotechnol, 2002, 20(4): 387-392.
36. Hartmann C H, Klein C A. Gene expression profiling of single cells on large-scale oligonucleotide arrays [J]. Nucleic Acids Res, 2006, 34 (21): e143.